Chang JY - Search Results

1

Novel oxime-bearing coumarin derivatives act as potent Nrf2/ARE activators in vitro and in mouse model.

Chang KM, Chen HH, Wang TC, Chen IL, Chen YT, Yang SC, Chen YL, Chang HH, Huang CH, Chang JY, Shih C, Kuo CC, Tzeng CC. Chang KM, et al. Among authors: chang hh, chang jy. Eur J Med Chem. 2015 Dec 1;106:60-74. doi: 10.1016/j.ejmech.2015.10.029. Epub 2015 Oct 19. Eur J Med Chem. 2015. PMID: 26519930

2

Antitumor AHMA linked to DNA minor groove binding agents: synthesis and biological evaluation.

Rastogi K, Chang JY, Pan WY, Chen CH, Chou TC, Chen LT, Su TL. Rastogi K, et al. Among authors: chang jy. J Med Chem. 2002 Sep 26;45(20):4485-93. doi: 10.1021/jm0200714. J Med Chem. 2002. PMID: 12238927

3

2,2'-Diphenyl-1-picrylhydrazyl radical-scavenging active components from adlay (Coix lachryma-jobi L. var. ma-yuen Stapf) hulls.

Kuo CC, Chiang W, Liu GP, Chien YL, Chang JY, Lee CK, Lo JM, Huang SL, Shih MC, Kuo YH. Kuo CC, et al. Among authors: chang jy. J Agric Food Chem. 2002 Oct 9;50(21):5850-5. doi: 10.1021/jf020391w. J Agric Food Chem. 2002. PMID: 12358449

4

New analogues of AHMA as potential antitumor agents: synthesis and biological activity.

Chang JY, Lin CF, Pan WY, Bacherikov V, Chou TC, Chen CH, Dong H, Cheng SY, Tasi TJ, Lin YW, Chen KT, Chen LT, Su TL. Chang JY, et al. Bioorg Med Chem. 2003 Nov 17;11(23):4959-69. doi: 10.1016/j.bmc.2003.09.001. Bioorg Med Chem. 2003. PMID: 14604658

5

Salvinal, a novel microtubule inhibitor isolated from Salvia miltiorrhizae Bunge (Danshen), with antimitotic activity in multidrug-sensitive and -resistant human tumor cells.

Chang JY, Chang CY, Kuo CC, Chen LT, Wein YS, Kuo YH. Chang JY, et al. Among authors: chang cy. Mol Pharmacol. 2004 Jan;65(1):77-84. doi: 10.1124/mol.65.1.77. Mol Pharmacol. 2004. PMID: 14722239

6

Three new oleanane-type triterpenes from Ludwigia octovalvis with cytotoxic activity against two human cancer cell lines.

Chang CI, Kuo CC, Chang JY, Kuo YH. Chang CI, et al. Among authors: chang jy. J Nat Prod. 2004 Jan;67(1):91-3. doi: 10.1021/np030267m. J Nat Prod. 2004. PMID: 14738395

7

Synthesis and structure-activity relationships of 3-aminobenzophenones as antimitotic agents.

Liou JP, Chang JY, Chang CW, Chang CY, Mahindroo N, Kuo FM, Hsieh HP. Liou JP, et al. Among authors: chang cw, chang jy, chang cy. J Med Chem. 2004 May 20;47(11):2897-905. doi: 10.1021/jm0305974. J Med Chem. 2004. PMID: 15139768

8

A novel bis-benzylidenecyclopentanone derivative, BPR0Y007, inducing a rapid caspase activation involving upregulation of Fas (CD95/APO-1) and wild-type p53 in human oral epidermoid carcinoma cells.

Juang SH, Pan WY, Kuo CC, Liou JP, Hung YM, Chen LT, Hsieh HP, Chang JY. Juang SH, et al. Among authors: chang jy. Biochem Pharmacol. 2004 Jul 15;68(2):293-303. doi: 10.1016/j.bcp.2004.03.036. Biochem Pharmacol. 2004. PMID: 15194001

9

BPR0L075, a novel synthetic indole compound with antimitotic activity in human cancer cells, exerts effective antitumoral activity in vivo.

Kuo CC, Hsieh HP, Pan WY, Chen CP, Liou JP, Lee SJ, Chang YL, Chen LT, Chen CT, Chang JY. Kuo CC, et al. Among authors: chang yl, chang jy. Cancer Res. 2004 Jul 1;64(13):4621-8. doi: 10.1158/0008-5472.CAN-03-3474. Cancer Res. 2004. PMID: 15231674

10

Concise synthesis and structure-activity relationships of combretastatin A-4 analogues, 1-aroylindoles and 3-aroylindoles, as novel classes of potent antitubulin agents.

Liou JP, Chang YL, Kuo FM, Chang CW, Tseng HY, Wang CC, Yang YN, Chang JY, Lee SJ, Hsieh HP. Liou JP, et al. Among authors: chang cw, chang yl, chang jy. J Med Chem. 2004 Aug 12;47(17):4247-57. doi: 10.1021/jm049802l. J Med Chem. 2004. PMID: 15293996

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,796 results

Search Page

Filters